MARKET

RADX

RADX

Radiopharm Theranostics Ltd
NASDAQ
4.082
-0.098
-2.34%
Opening 12:38 05/12 EDT
OPEN
4.200
PREV CLOSE
4.180
HIGH
4.200
LOW
4.050
VOLUME
22.46K
TURNOVER
--
52 WEEK HIGH
50.82
52 WEEK LOW
3.496
MARKET CAP
31.76M
P/E (TTM)
-0.3410
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RADX last week (0505-0509)?
Weekly Report · 5h ago
Radiopharm says DSMC says Phase 1 study may continue as planned
TipRanks · 5h ago
Radiopharm initiated with a Buy at ThinkEquity
TipRanks · 7h ago
Weekly Report: what happened at RADX last week (0428-0502)?
Weekly Report · 05/05 12:40
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 04/29 21:05
Weekly Report: what happened at RADX last week (0421-0425)?
Weekly Report · 04/28 12:56
Radiopharm Theranostic doses first patient with 18F-RAD101 in Phase 2b study
TipRanks · 04/28 12:44
Radiopharm Theranostics Doses First Patient In U.S. Phase 2B Imaging Study Of 18F-RAD101 In Suspected Recurrent Brain Metastasis
Benzinga · 04/28 12:02
More
About RADX
More
Radiopharm Theranostics Limited is an Australia-based clinical-stage radiotherapeutics company developing a platform of radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. The Company has a pipeline of highly differentiated molecules spanning peptides, small molecules and monoclonal antibodies for use in cancer, in pre-clinical and clinical stages of development. The clinical program includes one Phase II and two Phase I trials in a variety of solid tumor cancers including brain, lung, breast and pancreas. Its technologies include Nano-mAbs, Pivalate, AVB6 Integrin, PSA-mAb, and PTPu. Nano-mAbs is a novel radiopharmaceutical platform made using genetic engineered camelid derived single domain antibodies (sdAb) labelled with a radioisotope of therapeutic radiation. Pivalate is an 18F-FPIA radiotracer, based on a short chain carbohydrate which utilizes the early steps of fatty acid oxidation.
Recently
Symbol
Price
%Change

Webull offers Radiopharm Theranostics Ltd stock information, including NASDAQ: RADX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RADX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RADX stock methods without spending real money on the virtual paper trading platform.